Prognostic significance of suboptimal secondary prevention pharmacotherapy after acute coronary syndromes.

Matias B YudiOmar FarouqueNick AndrianopoulosAndrew E AjaniAngela BrennanAlexandra C MurphyJeffrey LefkovitsChristopher M ReidErnesto OqueliMartin SebastianStephen J DuffyDavid J Clarknull null

Published in: Internal medicine journal (2021)

There is a graded long-term hazard associated with not receiving OMT after an ACS. Improvements in secondary prevention pharmacotherapy models of care are warranted to further decrease the long-term mortality.

Keyphrases

acute coronary syndrome
smoking cessation
healthcare
palliative care
percutaneous coronary intervention
antiplatelet therapy
cardiovascular disease
type diabetes